Cited by 105HIV Research and TreatmentHIV/AIDS drug development and treatmentVirus-based gene therapy research

Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA

Open access
Poon, Betty, Chen, Irvin S. Y.·2003·Journal of Virology

Abstract

Retroviral DNA synthesized prior to integration, termed unintegrated viral DNA, is classically believed to be transcriptionally inert and to serve only as a precursor to the transcriptionally active integrated proviral DNA form. However, it has recently been found to be expressed under some circumstances during human immunodeficiency virus type 1 (HIV-1) replication and may play a significant role in HIV-1 pathogenesis. HIV-1 Vpr is a virion-associated accessory protein that is critical for HIV-1 replication in nondividing cells and induces cell cycle arrest and apoptosis. We find that Vpr, either expressed de novo or released from virions following viral entry, is essential for unintegrated viral DNA expression. HIV-1 mutants defective for integration in either the integrase catalytic domain or the cis -acting att sites can express unintegrated viral DNA at levels similar to that of wild-type HIV-1, but only in the presence of Vpr. In the absence of Vpr, the expression of unintegrated viral DNA decreases 10- to 20-fold. Vpr does not affect the efficiency of integration from integrase-defective HIV-1. Vpr-mediated enhancement of expression from integrase-defective HIV-1 requires that the viral DNA be generated in cells through infection and is mediated via a template that declines over time. Vpr activation of expression does not require exclusive nuclear localization of Vpr nor does it correlate with Vpr-mediated cell cycle arrest. These results attribute a new function to HIV-1 Vpr and implicate Vpr as a critical component in expression from unintegrated HIV-1 DNA.

Integrity signals

Registry

Crossref · 10.1128/jvi.77.7.3962-3972.2003

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Retaining the Vpr accessory protein via transcriptional activation of the HIV-1 LTR can enhance expression of integrase-defective lentiviral vectors.

    “Another approach to enhance the expression of integrase-defective LVs is by retaining the Vpr accessory protein via transcriptional activation of the HIV-1 LTR [74].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Poon, B., & Chen, I. S. Y.
Affiliations
University of California, Los Angeles (US)
Venue
Journal of Virology
Published
2003-04
Volume
77
Issue
7
Pages
3962-3972
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2108498026
Cited by
105
References
2
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 6 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 5
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (CA70018, R01CA070018)
  • National Institute of Allergy and Infectious Diseases (AI-28 697, AI 43190, R01AI043190, P30AI028697)
  • Center for AIDS Research, University of California Los Angeles
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
HIV-1 Vpr, unintegrated viral DNA, HIV-1 transcription, viral integration, integrase, att site, accessory proteins, viral pathogenesis, cell cycle arrest, apoptosis
MeSH terms
Cell Line, Defective Viruses, DNA, Viral, HeLa Cells, Humans, Transcription, Genetic, HIV-1, Transcriptional Activation, Up-Regulation, Gene Expression, HIV Long Terminal Repeat, Genes, vpr, Gene Products, vpr, Virus Integration, HIV Integrase, vpr Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review